Calliditas Therapeutics’ American depositary receipts jumped more than 70% premarket on Tuesday after a nearly $1.1 billion takeover bid from a Japanese conglomerate.
Calliditas Therapeutics’ stock surges after $1.1 billion takeover bid
Read Next
- Plane tickets are getting cheaper as domestic travel demand weakens
- Union Bank Report, ET BFSI
- More Americans buy groceries with buy now, pay later loans
- SC allows RBI to start fresh proceedings against big defaulters, ET BFSI
- Trump and Ukraine’s Zelenskyy have ‘very productive’ meeting in Rome
- RBI to auction new 10-year benchmark bond next week, ET BFSI
- U.S. Education Dept investigates UC Berkeley’s foreign funding disclosures
